Abstract
PURPOSE OF REVIEW
Pneumothorax is a global health problem. To date, there is still significant variation in the management of pneumothorax. For the past few years, there have been significant developments in the outpatient management of both primary and secondary spontaneous pneumothorax (SSP). We will review the latest evidence for the management of nontraumatic pneumothorax (spontaneous and iatrogenic) to include pneumothorax associated with COVID-19 infection.
RECENT FINDINGS
Outpatient management of both primary and SSP may be safe and feasible.
SUMMARY
Outpatient management of both primary and SSP should be included in treatment options discussion with patients.
Collapse